Drug Shortage Report for PMS-CYTARABINE
| Report ID | 146890 |
| Drug Identification Number | 02406772 |
| Brand name | PMS-CYTARABINE |
| Common or Proper name | CYTARABINE |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CYTARABINE |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRATHECAL SUBCUTANEOUS INTRAVENOUS INTRATHECAL |
| Packaging size | 2000mg/20mL |
| ATC code | L01BC |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-01-04 |
| Actual start date | |
| Estimated end date | 2022-02-25 |
| Actual end date | 2022-02-15 |
| Shortage status | Resolved |
| Updated date | 2022-02-16 |
| Company comments | Limited supply. Anticipated BO from January 4, 2022 to February 25, 2022 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v16 | 2022-02-16 | French | Compare |
| v15 | 2022-02-16 | English | Compare |
| v14 | 2022-01-05 | English | Compare |
| v13 | 2021-12-01 | French | Compare |
| v12 | 2021-12-01 | English | Compare |
| v11 | 2021-11-23 | French | Compare |
| v10 | 2021-11-23 | English | Compare |
| v9 | 2021-11-08 | French | Compare |
| v8 | 2021-11-08 | English | Compare |
| v7 | 2021-11-05 | French | Compare |
| v6 | 2021-11-05 | English | Compare |
| v5 | 2021-11-05 | English | Compare |
| v4 | 2021-10-28 | French | Compare |
| v3 | 2021-10-28 | English | Compare |
| v2 | 2021-10-07 | French | Compare |
| v1 | 2021-10-07 | English | Compare |
Showing 1 to 16 of 16